Literature DB >> 26920654

Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study.

B Bonaz1,2, V Sinniger1,2, D Hoffmann3, D Clarençon2, N Mathieu1, C Dantzer4, L Vercueil5, C Picq2, C Trocmé6, P Faure7, J-L Cracowski8, S Pellissier2,4.   

Abstract

The vagus nerve (VN) is a link between the brain and the gut. The VN is a mixed nerve with anti-inflammatory properties through the activation of the hypothalamic-pituitary-adrenal axis by its afferents and by activating the cholinergic anti-inflammatory pathway through its efferents. We have previously shown that VN stimulation (VNS) improves colitis in rats and that the vagal tone is blunted in Crohn's disease (CD) patients. We thus performed a pilot study of chronic VNS in patients with active CD. Seven patients under VNS were followed up for 6 months with a primary endpoint to induce clinical remission and a secondary endpoint to induce biological (CRP and/or fecal calprotectin) and endoscopic remission and to restore vagal tone (heart rate variability). Vagus nerve stimulation was feasible and well-tolerated in all patients. Among the seven patients, two were removed from the study at 3 months for clinical worsening and five evolved toward clinical, biological, and endoscopic remission with a restored vagal tone. These results provide the first evidence that VNS is feasible and appears as an effective tool in the treatment of active CD.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Crohn's disease; cholinergic anti-inflammatory pathway; heart rate variability; vagus nerve; vagus nerve stimulation

Mesh:

Year:  2016        PMID: 26920654     DOI: 10.1111/nmo.12792

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  142 in total

1.  Effect of transcutaneous vagus nerve stimulation on muscle activity in the gastrointestinal tract (transVaGa): a prospective clinical trial.

Authors:  Gun-Soo Hong; Bogdan Pintea; Philipp Lingohr; Christoph Coch; Thomas Randau; Nico Schaefer; Sven Wehner; Joerg C Kalff; Dimitrios Pantelis
Journal:  Int J Colorectal Dis       Date:  2018-12-05       Impact factor: 2.571

Review 2.  Overview of therapeutic applications of non-invasive vagus nerve stimulation: a motivation for novel treatments for systemic lupus erythematosus.

Authors:  Charrise M Ramkissoon; Amparo Güemes; Josep Vehi
Journal:  Bioelectron Med       Date:  2021-05-25

Review 3.  Mechanisms and Therapeutic Relevance of Neuro-immune Communication.

Authors:  Sangeeta S Chavan; Valentin A Pavlov; Kevin J Tracey
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

4.  Vagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway.

Authors:  Evilin Naname Komegae; David George Stephen Farmer; Virginia Leah Brooks; Michael Joseph McKinley; Robin Michael McAllen; Davide Martelli
Journal:  Brain Behav Immun       Date:  2018-06-05       Impact factor: 7.217

Review 5.  Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation.

Authors:  Bruno Bonaz; Valérie Sinniger; Sonia Pellissier
Journal:  J Physiol       Date:  2016-05-01       Impact factor: 5.182

6.  Electroceutical Targeting of the Autonomic Nervous System.

Authors:  Charles C Horn; Jeffrey L Ardell; Lee E Fisher
Journal:  Physiology (Bethesda)       Date:  2019-03-01

7.  Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.

Authors:  Fernanda M Consolim-Colombo; Carine T Sangaleti; Fernando O Costa; Tercio L Morais; Heno F Lopes; Josiane M Motta; Maria C Irigoyen; Luiz A Bortoloto; Carlos Eduardo Rochitte; Yael Tobi Harris; Sanjaya K Satapathy; Peder S Olofsson; Meredith Akerman; Sangeeta S Chavan; Meggan MacKay; Douglas P Barnaby; Martin L Lesser; Jesse Roth; Kevin J Tracey; Valentin A Pavlov
Journal:  JCI Insight       Date:  2017-07-20

Review 8.  AKI and the Neuroimmune Axis.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

9.  The development of neural stimulators: a review of preclinical safety and efficacy studies.

Authors:  Robert K Shepherd; Joel Villalobos; Owen Burns; David A X Nayagam
Journal:  J Neural Eng       Date:  2018-05-14       Impact factor: 5.379

Review 10.  Electroceuticals in the Gastrointestinal Tract.

Authors:  Khalil B Ramadi; Shriya S Srinivasan; Giovanni Traverso
Journal:  Trends Pharmacol Sci       Date:  2020-10-27       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.